Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ann Surg Oncol. 2021 Jul;28(7):3532-3544. doi: 10.1245/s10434-021-09798-y. Epub 2021 Mar 11.
Few Western studies have evaluated the long-term oncologic outcomes of minimally invasive surgery (MIS) approaches to gastrectomy for gastric cancer. This study aimed to compare the outcomes between minimally invasive and open gastrectomies and between laparoscopic and robotic gastrectomies at a high-volume cancer center in the United States.
The study analyzed data for all patients undergoing curative gastrectomy for gastric adenocarcinoma from January 2007 to June 2017. Postoperative complications and disease-specific survival (DSS) were compared between surgical approaches.
The median follow-up period for the 845 patients in this study was 38.5 months. The stage-stratified 5-year DSS did not differ significantly between open surgery (n = 534) and MIS (n = 311). The MIS approach resulted in significantly fewer complications, as confirmed by adjusted comparison (odds ratio [OR], 0.70; range, 0.49-1.00; p = 0.049). After adjustment, the two groups did not differ in terms of DSS (hazard ratio [HR], 0.83; range, 0.55-1.25; p = 0.362). The robotic operations (n = 190) had fewer conversions to open procedure (p = 0.010), a shorter operative time (212 vs 240 min; p < 0.001), more dissected nodes (27 vs 22; p < 0.001), fewer Clavien-Dindo grade ≥3 complications (5.8% vs 13.2%; p = 0.023), and a shorter postoperative stay (5 vs 6 days; p = 0.045) than the laparoscopic operations (n = 121). The DSS rate did not differ between the laparoscopic and robotic groups.
The study findings demonstrated the long-term survival and oncologic equivalency of MIS gastrectomy and the open approach in a Western cohort, supporting the use of MIS at centers that have adequate experience with appropriately selected patients.
西方很少有研究评估过微创外科(MIS)方法治疗胃癌的长期肿瘤学结果。本研究旨在比较美国一家高容量癌症中心的微创与开放胃切除术以及腹腔镜与机器人胃切除术之间的结果。
该研究分析了 2007 年 1 月至 2017 年 6 月期间接受胃腺癌根治性胃切除术的所有患者的数据。比较了手术方法之间的术后并发症和疾病特异性生存率(DSS)。
本研究中 845 例患者的中位随访时间为 38.5 个月。分层 5 年 DSS 在开放手术(n=534)和 MIS(n=311)之间无显著差异。通过调整比较证实,MIS 方法导致的并发症明显更少(优势比[OR],0.70;范围,0.49-1.00;p=0.049)。调整后,两组在 DSS 方面无差异(风险比[HR],0.83;范围,0.55-1.25;p=0.362)。机器人手术(n=190)中转开腹手术的比例更低(p=0.010),手术时间更短(212 分钟比 240 分钟;p<0.001),清扫的淋巴结更多(27 个比 22 个;p<0.001),Clavien-Dindo 分级≥3 的并发症更少(5.8%比 13.2%;p=0.023),术后住院时间更短(5 天比 6 天;p=0.045),腹腔镜手术(n=121)。腹腔镜和机器人组之间的 DSS 率没有差异。
研究结果表明,在西方队列中,MIS 胃切除术和开放方法具有长期生存和肿瘤学等效性,支持在有足够经验且选择合适患者的中心使用 MIS。